RSS

RMHB Rocky Mountain High Brands, Inc.

Last Post: 09/27/26
Followers: 450
Posts Today: 0
Views Today: 23569

RMHB Stock Quote & Tools

$0.0014 ▼ -0.0004 (-22.22%) As of Oct 27, 11:50 AM EDT
Last0.0014
$ Chg-0.0004
Open0.0015
High0.0015
Beta0.7702
Year High0.005
Market Cap1.26M
P/B Ratio-0.87
EPS-0.04
Avg Vol (30d)130.2K
Volume139.7K
% Chg-22.22%
Prev Close0.0018
Low0.0014
VWAP0.00147
Year Low0.000
Total Shares899.47M
Shares Out899.47M
Float890.47M
ExchangeOTCID
Consumer Staples Beverages - Non-Alcoholic

RMHB Stock Message Board Discussion

  1. Veryskilled21
  2. moneygirl

Top 10 Most Recent News Articles

Navigating Market Uncertainty with Financial Planning

Updated Category News Views 19

Staying Calm Amid Market Chaos The market's like a roller coaster more often than not, and when headlines scream panic, even the most seasoned of us can begin to doubt our strategies. Jennifer Prosise from The Voyager Group, Ltd., in Joliet, IL, calls out this high-stakes game in HelloNation, emphasizing how financial planning serves as our anchor in the stormy seas of...

Continue Reading
Posterity Health Boosts Network to Six New Markets

Updated Category News Views 132

Expansion at Breakneck Speed Just like that, we've got Posterity Health making power moves across the country, staking claim in six major markets. Denver's very own fertility platform is on a roll, and this ain't just any rollout. We're talking partnerships like confetti in the air, dotting spots from the sunny Cali shores of Orange County to the bustling streets of...

Continue Reading
Ferrovial's 2026 Growth: North America Drives Success

Updated Category News Views 22

Solid Gains Across the Board Right off the bat, Ferrovial's 2026 report card screams 'win'. For the first three quarters, they clocked in a hefty 21.8% boost in adjusted EBITDA, and revenue didn't dawdle either, climbing 10.8%—not exactly a stroll in the park to accomplish. North America's No Joke Ferrovial's got a clear hero in their narrative and it's North America....

Continue Reading
Atrium's ATR 1072 Doses First in Genetic Cardiomyopathy Trial

Updated Category News Views 44

Atrium's Leap in Genetic Cardiomyopathy You know you're living in fascinating times when a company like Atrium Therapeutics rolls the dice on RNA therapeutics, aiming to tackle heart diseases at the genetic level. And that's precisely what they did! They just dosed the first patient in the Phase 1/2 Corventis trial with their drug ATR 1072, setting sail on uncharted...

Continue Reading
Preston Dermatology Earns Gold in Raleigh Awards

Updated Category News Views 37

Celebrating a Winning Streak Stroll around Raleigh, and you'll hear buzz about Preston Dermatology & Skin Surgery Center clinching Gold in the annual Raleigh's Best Awards for the second year running. This dermatology practice isn't just another name in the area—it's become a beacon for people seeking quality skin care around the Triangle. Both the practice and its...

Continue Reading
Japanese Hair Care Brand &honey Garners Top U.S. Award

Updated Category News Views 114

Hydration Reigns in Hair Care Here's something that'll make your average shampoo tremble in its plastic boots: Japan's &honey Deep Moist Shampoo has snagged the spot as Best Drugstore Shampoo for 2026, according to the Marie Claire Beauty Awards. It’s not some trivial title, folks. In a market flooded with every hair-elixir promise under the sun, getting this nod is...

Continue Reading
OLX Rolls Out New AI Tools Amid Trust Issues

Updated Category News Views 0

A Grounded Approach to AI-Driven Market Evolution OLX Group's stepping into some turbulent waters, folks. They've dropped two new AI-assisted tools, Agentic Selling and DealFinder, while users are still trying to wrap their heads around trusting AI. Now, don't get me wrong, there's potential here—but the road ahead isn't paved with gold just yet. AI-Powered Tools Ready...

Continue Reading
Americans' Faith in Democracy Hits New Lows

Updated Category News Views 128

Polarization Beyond Politics: A National Reckoning When you catch wind of a report like this one, it's enough to make you feel like the fabric of democracy is unraveling right before our eyes. We're staring at a national identity crisis, folks, and it's got nothing to do with whether you're waving a red or blue flag. This ain't about party lines; it's about a bigger,...

Continue Reading
Right Heart Failure Gains Recognition as Its Own Syndrome

Updated Category News Views 24

Changing the Narrative on Right Heart Failure How often do we see right heart failure (RHF) brushed aside like some understudy in the grand play of cardiovascular disease? Far too often, according to the Heart Failure Society of America (HFSA). They're here to shift that narrative, demanding RHF be recognized for what it truly is: a distinct clinical syndrome. Forget...

Continue Reading
CMS Energy's Q3 Marks Change: Restructuring Boost

Updated Category News Views 71

A Tale of Two Earnings Few things get my blood pumping like a new quarter's earnings dance, and CMS Energy (NYSE:CMS) is stealing the show right now with its two-faced Q3 results. Digging deep into the numbers, we see this Michigan-based energy player reporting a gauntlet of figures that have investors raising their eyebrows. On one hand, reported GAAP earnings dropped to...

Continue Reading

Top 5 Most Recently Viewed Articles

Samsonite Group Reports Mixed Financial Performance in Q3 2025

Updated Category News Views 268

Samsonite Group Q3 2025 Financial Overview In the third quarter ended September 30, 2025, Samsonite Group reported consolidated net sales of US$872.7 million. This marks a slight decrease of 1.3% year-over-year; however, it's a sequential improvement from a net sales drop of 5.8% seen in the prior quarter. The company achieved a robust gross profit margin of 59.6% and an...

Continue Reading
Jim Cramer's Caution on Dorman Products and Market Trends

Updated Category News Views 160

Insights from Jim Cramer on Dorman Products On a recent episode of CNBC's “Mad Money Lightning Round,” Jim Cramer provided insights on the stock market, particularly urging investors to steer clear of Dorman Products, Inc. (NASDAQ: DORM). He characterized the current state of housing and automotive markets as challenging, stating, “The only thing worse than housing...

Continue Reading
Visa Inc. Faces Securities Class Action Amid Legal Scrutiny

Updated Category News Views 74

Visa Inc. Faces Potential Securities Class Action Rosen Law Firm, known for advocating investor rights, has launched an investigation into potential securities claims on behalf of investors in Visa Inc. The firm believes that allegations suggest Visa may have presented misleading business information to the public. Such claims have raised concern among shareholders,...

Continue Reading
XAI Octagon Floating Rate Trust Announces Distribution Updates

Updated Category News Views 181

XAI Octagon Floating Rate Trust's Recent Distribution Announcements XAI Octagon Floating Rate & Alternative Income Trust has declared its latest monthly distribution for common shares, valued at $0.077 each. Additionally, the Trust announced quarterly dividends of $0.40625 for its 6.50% Series 2026 Term Preferred Shares. These decisions reflect the Trust's ongoing...

Continue Reading
TCBY Celebrates 45 Years of Sweet Community Bonds

Updated Category News Views 30

From Flavor Revolution to Community Evolution Who'd have thought that a frozen treat could turn into an essential piece of Americana? That's exactly what TCBY, a pioneer in the frozen yogurt space, has achieved over the last 45 years. This summer, they're not just celebrating their past but also galvanizing a community spirit with a heady mix of nostalgia and innovation....

Continue Reading